Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-14-023685
Filing Date
2014-04-21
Accepted
2014-04-21 06:56:06
Documents
12
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v374510_10k.htm 10-K 1144008
2 EXHIBIT 10.44 v374510_ex10-44.htm EX-10.44 55316
3 EXHIBIT 10.45 v374510_ex10-45.htm EX-10.45 98655
4 EXHIBIT 10.47 v374510_ex10-47.htm EX-10.47 26958
5 EXHIBIT 10.48 v374510_ex10-48.htm EX-10.48 54497
6 EXHIBIT 21 v374510_ex21.htm EX-21 2120
7 EXHIBIT 23.1 v374510_ex23-1.htm EX-23.1 2596
8 EXHIBIT 23.2 v374510_ex23-2.htm EX-23.2 4989
9 EXHIBIT 31.1 v374510_ex31-1.htm EX-31.1 8001
10 EXHIBIT 31.2 v374510_ex31-2.htm EX-31.2 8214
11 EXHIBIT 32.1 v374510_ex32-1.htm EX-32.1 3716
12 EXHIBIT 32.2 v374510_ex32-2.htm EX-32.2 3993
  Complete submission text file 0001144204-14-023685.txt   1414429
Mailing Address C/O JANSSEN LABS @ QB3 953 INDIANA STREET SAN FRANCISCO CA 94107
Business Address C/O JANSSEN LABS @ QB3 953 INDIANA STREET SAN FRANCISCO CA 94107 (408) 737-2734
Amarantus Bioscience Holdings, Inc. (Filer) CIK: 0001424812 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55016 | Film No.: 14772774
SIC: 2834 Pharmaceutical Preparations